ClinicalTrials.gg
Sign In

Hematoma, Subdural, Chronic clinical trials

The registry lists 112 studies for Hematoma, Subdural, Chronic across more than 10 countries. 49 are recruiting or about to start. 108 of them are mainly about Hematoma, Subdural, Chronic (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-06.

Get an email when these change. Save the Hematoma, Subdural, Chronic studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Recruiting
35
Completed
26
Status unknown
20
Not yet recruiting
14
Terminated
7
Withdrawn
6

Phase

Phase 2
12
Phase 3
12
Phase 4
4
Phase 1
3
Early Phase 1
2

Where

United States
21
China
17
Canada
8
France
7
Germany
6
Sweden
5

Who runs them

Beijing Tiantan Hospital (6) · University of New Mexico (3) · Chinese University of Hong Kong (3) · Unity Health Toronto (2) · St. Olavs Hospital (2) · Sahlgrenska University Hospital (2) · The Second Hospital of Anhui Medical University (2) · Icahn School of Medicine at Mount Sinai (2)

What is being tested here

Drugs under test in Hematoma, Subdural, Chronic studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Tranexamic Acid346
Bevacizumab102
Dexmedetomidine101
Amoxicillin111
Clavulanic Acid111
Dexamethasone024
Atorvastatin013
Magnesium Sulfate002
Aspirin001
Fentanyl001

Drug classes tested here Corticosteroids 5

Coming up

4phase 3 studies under way
19studies finish main data collection within a year1 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 35 Hematoma, Subdural, Chronic studies recruiting now, 26 (74%) set no upper age limit and 1 (3%) stop at 75 or younger. 1 (3%) take children under 18. 0 (0%) are for women only and 1 (3%) for men only; 1 (3%) take healthy volunteers.

Recruiting studies that take each age, of 35
AgeWomenMen
100 (0%)1 (3%)
1830 (86%)31 (89%)
3030 (86%)31 (89%)
4031 (89%)32 (91%)
5033 (94%)34 (97%)
6534 (97%)35 (100%)
7533 (94%)34 (97%)
8532 (91%)33 (94%)

Across all 112 studies, recruiting or not: 3% stop at 75 or younger and 2% at 65; 4% take children; 0% are for women only and 1% for men only; 8% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Hematoma, Subdural, Chronic studies take

Of 44 interventional studies with no phase under Hematoma, Subdural, Chronic, half reached primary completion within 45 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase45 mo37–70 · 44 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 13, 2026.

Started recruiting2

Stopped1

Newly registered1

Studies

Recruiting first, then most recently updated. Showing 50 of 112. Browse all 112 → or search them.